OXRE(OXBR)

Search documents
OXRE(OXBR) - 2023 Q2 - Quarterly Report
2023-08-14 20:04
Business Operations - Oxbridge Re Holdings Limited focuses on fully collateralized reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region, especially Florida [151]. - During the six-month period ending June 30, 2023, SurancePlus Inc. entered into subscription agreements for the sale of its Series DeltaCat Re tokens, representing fractionalized interest in reinsurance contracts [175]. - The business combination with Jet Token Inc. was completed on August 10, 2023, enabling Jet to continue its growth strategy of AI software development and fleet expansion [165]. Financial Performance - Total revenue for the three months ended June 30, 2023, was $691,000, an increase of 37.5% compared to $503,000 for the same period in 2022 [181]. - Net premiums earned for the six months ended June 30, 2023, decreased to $183,000 from $404,000 for the same period in 2022, representing a decline of 54.7% [184]. - General and administrative expenses for the six months ended June 30, 2023, increased to $1.1 million, up from $728,000 in the same period in 2022, reflecting a rise of 50.9% [188]. - The combined ratio for the six months ended June 30, 2023, increased to 601.6% from 191.1% in the same period in 2022, indicating a significant decline in underwriting performance [195]. - Net loss for the quarter ended June 30, 2023, was $85,000, compared to a net income of $77,000 for the same period in 2022 [181]. Cash and Investments - As of June 30, 2023, restricted cash and cash equivalents decreased by $2.35 million, or 86%, to $0.37 million from $2.72 million as of December 31, 2022 [195]. - Total investments increased by $81,000, or 13%, to $723,000 as of June 30, 2023, from $642,000 as of December 31, 2022 [196]. - Other investments increased by $505,000 to $11.93 million from $11.42 million at December 31, 2022, due to fair value changes [197]. - Net cash used in operating activities for the six months ended June 30, 2023, totaled $1,614,000, compared to $475,000 for the same period in 2022 [206]. - Notes payable to noteholders decreased by $46,000 to $118,000 as of June 30, 2023, from $216,000 at December 31, 2022 [198]. Reserves and Losses - As of June 30, 2023, the company had no reserves for loss and loss adjustment expenses due to no significant events occurring during the year and no reported claims on contracts in force [221]. - The reserves for losses and loss adjustment expenses are based on claims reported by ceding insurers and independent actuary assistance, representing management's best estimate of ultimate settlement costs [218]. - The company believes its loss reserves are adequate, but acknowledges the uncertainty in predicting future events, which could lead to material differences in required settlement amounts [219]. - Under GAAP, the company cannot establish loss reserves until an actual loss event occurs, limiting reserves to losses incurred up to the reporting date [220]. - The company's reserving methodology involves arriving at a specific point estimate for expected losses on a contract-by-contract basis due to the low frequency and high severity nature of claims [222]. Revenue Recognition - The company records premium revenue as earned pro-rata over the terms of reinsurance agreements, with unearned premiums recorded as a reserve [215]. - The company assesses reinsurance contracts for risk transfer, which is critical for reporting premiums written; if insufficient risk is transferred, the contract is accounted for as a deposit liability [217]. Investment Valuation - The fair value of investments is based on the last traded price, with indirect investments evaluated by independent valuation experts using observable and unobservable inputs [214]. - The determination of what constitutes "observable" data requires significant judgment by the company's investment custodians and management [214].
OXRE(OXBR) - 2023 Q1 - Earnings Call Transcript
2023-05-12 23:48
Oxbridge Re Holdings Limited (NASDAQ:OXBR) Q1 2023 Earnings Conference Call May 12, 2023 4:30 PM ET Company Participants Wrendon Timothy - Chief Financial Officer & Corporate Secretary Jay Madhu - Chairman, President & Chief Executive Officer Conference Call Participants Kent Engelke - Capitol Securities Operator Good afternoon and welcome to Oxbridge Re's First Quarter 2023 Earnings Call. My name is Camilla and I will be your conference operator this afternoon. At this time, all participants are in a liste ...
OXRE(OXBR) - 2023 Q1 - Quarterly Report
2023-05-12 20:19
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. (Mark One) Yes ☒ No ☐ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECUR ...
OXRE(OXBR) - 2022 Q4 - Earnings Call Transcript
2023-03-30 23:33
Financial Data and Key Metrics Changes - Net premiums earned increased marginally to $995,000 in 2022 from $965,000 in 2021, primarily due to the acceleration of premium recognition on two reinsurance contracts and higher rates on reinsurance contracts [12] - The company experienced a net loss of $1.8 million or $0.31 per share in 2022, compared to net income of $8.6 million in 2021 [13] - Total revenue declined to $850,000 in 2022 from $10.2 million in the prior year, mainly due to a significant decline in unrealized gains on SPAC investments [20] - The loss ratio increased to 107.8% in 2022 from 16.4% in the prior year, attributed to losses from Hurricane Ian [45] - The combined ratio rose to 260.9% in 2022 from 162.6% in 2021, reflecting increased loss and administrative expenses [46] Business Line Data and Key Metrics Changes - The acquisition cost ratio remained stable at 11% in 2022 compared to the prior year [22] - The expense ratio increased to 153.1% in 2022 from 146.2% in the prior year, primarily due to higher general and administrative expenses [22] Market Data and Key Metrics Changes - The investment portfolio increased to $642,000 at December 31, 2022, from $577,000 in the prior year, mainly due to net purchases of equity securities [23] - Cash and cash equivalents decreased to $3.9 million at December 31, 2022, compared to $5.4 million at December 31, 2021 [24] Company Strategy and Development Direction - The company launched SurancePlus, a subsidiary that will issue tokenized reinsurance securities, aiming to democratize access to reinsurance investments [25][49] - The first offering of SurancePlus tokens is expected to raise up to $5 million, with potential returns of up to 196% over three years [26] - The company remains opportunistic about its core reinsurance business and is focused on diversifying its investment portfolio [11][51] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the prospects of the core reinsurance business and the potential of new investments in emerging technologies [11][52] - The current volatility in global financial markets is impacting the investment portfolio and net income, but the company is positioned to capitalize on favorable return opportunities [18] Other Important Information - The company remains debt-free and has a strong balance sheet, positioning itself for growth in emerging technologies [52] - The company is focused on maintaining operational efficiencies and managing costs effectively [57] Q&A Session Summary Question: Clarification on SPAC investments - The company owns approximately 1.4 million shares in Oxbridge Acquisition Corp, with a cost basis of about $2.3 million, and the shares are expected to be worth $14 million at closing [54] Question: Details on reinsurance tokens offering - The first offering is about $5 million, with Oxbridge taking a small management fee and sharing profits on an 80-20 basis after the first 20% return to investors [57]
OXRE(OXBR) - 2022 Q4 - Annual Report
2023-03-30 20:59
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For The Transition Period From ________ To ________ Commission File Number 1-36346 OXBRIDGE RE HOLDINGS LIMITED (Exact name of registrant as specified in its charter) Cayman Islands 98-1150254 (State or ot ...
OXRE(OXBR) - 2022 Q3 - Earnings Call Transcript
2022-11-15 02:29
Oxbridge Re Holdings Ltd (NASDAQ:OXBR) Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Wrendon Timothy - CFO, Secretary & Director Sanjay Madhu - Chairman, President & CEO Conference Call Participants Kent Engelke - Capitol Securities Management Operator Good afternoon. Welcome to Oxbridge Re's Third Quarter 2022 Earnings Call. My name is Karen, and I will be your conference operator this afternoon. [Operator Instructions]. Joining us for today's presentation is Oxbridge R ...
OXRE(OXBR) - 2022 Q3 - Quarterly Report
2022-11-14 21:01
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number: 1-36346 OXBRIDGE RE HOLDINGS LIMITED (Exact name of registrant as specified in its charter) | Cayman Islands ...
OXRE(OXBR) - 2022 Q2 - Earnings Call Transcript
2022-08-16 07:58
Financial Data and Key Metrics Changes - Net premiums earned for the first six months of 2022 increased due to a higher weighted average rate on reinsurance contracts in force [13] - Total revenue declined to $505,000 for the first six months of 2022 compared to $1.1 million last year [14] - Net income for the three months ended June 30, 2022, was $77,000, down from $448,000 in 2021; for the first six months, a net loss of $310,000 was reported compared to net income of $476,000 [15] - The combined ratio increased to 191.1% for the first six months of 2022 compared to 157.3% last year, primarily due to higher general and administrative expenses [19] Business Line Data and Key Metrics Changes - The loss ratio remained at zero for both the first six months of 2022 and 2021, indicating no loss or loss adjustment expenses incurred [17] - The acquisition cost ratio remained stable at 10.9% for both periods, with a slight increase in the second quarter of 2022 [18] Market Data and Key Metrics Changes - The investment portfolio increased by $600,000 to $638,000 at June 30, 2022, from $577,000 at year-end, despite annualized losses due to volatile capital markets [20] - Cash and cash equivalents decreased to $4.6 million at June 30, 2022, compared to $5.4 million at December 31, 2021 [20] Company Strategy and Development Direction - The company aims to achieve long-term growth in book value per share by writing business selectively and opportunistically to generate attractive underwriting profits [8] - The investment in Oxbridge Acquisition Corp. focuses on disruptive technologies such as DeFi, blockchain, insurtech, artificial intelligence, and clean energy [10][22] - The company remains optimistic about the long-term prospects of its core reinsurance business and its investment in the SPAC [12] Management's Comments on Operating Environment and Future Outlook - Management noted that the negative impact of the COVID-19 pandemic is receding, but inflationary cost pressures and supply chain disruptions are affecting the broader economy [11] - The company is optimistic about the recovery of equity markets and its investment portfolio, which has shown signs of improvement [12] Other Important Information - The company remains debt-free and has a strong balance sheet with a solid cash position [22] - Management emphasized the importance of diversification in its business model to capitalize on growth opportunities [22] Q&A Session Summary Question: Update on SPAC closing timeline - Management indicated that they are in a solid position regarding the SPAC and have extensions available until May 2023 to finalize any deals [28][30] Question: Insights on investment opportunities outside SPAC and reinsurance - Management acknowledged seeing tremendous opportunities in various businesses and emphasized the importance of timing in evaluating these opportunities [33] Question: Concerns about insider selling - Management clarified that the individual mentioned is not an insider and that the company does not comment on other people's investments [41][42]
OXRE(OXBR) - 2022 Q2 - Quarterly Report
2022-08-15 20:18
Financial Performance - For the three months ended June 30, 2022, net premiums earned were $194,000, a decrease from $205,000 in the same period of 2021[161]. - Net income for the quarter ended June 30, 2022, was $77,000, or $0.01 per share, compared to a net income of $448,000, or $0.08 per share, for the same quarter in 2021[161]. - Total revenue for the six months ended June 30, 2022, was $505,000, down from $1,125,000 in the same period of 2021[161]. - The company reported a net loss of $310,000, or ($0.05) per share, for the six months ended June 30, 2022, compared to a net income of $476,000, or $0.08 per share, for the same period in 2021[161]. Underwriting and Expense Ratios - The combined ratio for the three months ended June 30, 2022, was 211.3%, compared to 162.9% for the same period in 2021[162]. - The loss ratio for the three and six-month periods ended June 30, 2022, was 0%, indicating no losses incurred during these periods[169]. - The acquisition cost ratio increased from 10.7% for the quarter ended June 30, 2021, to 10.8% for the same quarter in 2022, while remaining consistent at 10.9% for the six-month periods[170][171]. - The expense ratio increased from 162.9% for the three-month period ended June 30, 2021, to 211.3% for the same period in 2022, and from 157.3% to 191.1% for the six-month periods[172][173]. - The combined ratio increased from 162.9% for the three-month period ended June 30, 2021, to 211.3% for the same period in 2022, and from 157.3% to 191.1% for the six-month periods[174][175]. Premiums and Investment Income - Assumed premiums for the three months ended June 30, 2022, were $669,000, down from $1,014,000 in the same period of 2021[161]. - Net investment and other income for the three months ended June 30, 2022, was $41,000, compared to $23,000 in the same period of 2021[161]. - The company experienced a significant decline in net realized investment gains, reporting $19,000 for the three months ended June 30, 2022, compared to $755,000 in the same period of 2021[161]. - The change in fair value of equity securities resulted in a loss of $322,000 for the three months ended June 30, 2022[161]. Operating Expenses - Policy acquisition costs and underwriting expenses for the quarter ended June 30, 2022, decreased marginally to $21 thousand from $22 thousand for the same quarter in 2021, but increased to $44 thousand from $42 thousand for the six months ended June 30, 2022[164][165]. - General and administrative expenses for the quarter ended June 30, 2022, increased to $389 thousand from $312 thousand for the same quarter in 2021, and for the six months ended June 30, 2022, increased to $728 thousand from $565 thousand[165][166]. Cash and Reserves - As of June 30, 2022, restricted cash and cash equivalents increased by $281 thousand, or 15%, to $2.17 million from $1.89 million as of December 31, 2021[175]. - As of June 30, 2022, unearned premiums reserve increased by $241 thousand, or 69%, to $591 thousand from $350 thousand at December 31, 2021[179]. - Net cash used in operating activities for the six months ended June 30, 2022, totaled $475 thousand, compared to $208 thousand for the same period in 2021[186][187]. Deferred Acquisition Costs - The company defers certain expenses related to producing reinsurance business, including brokerage fees and premium taxes, which are capitalized as deferred acquisition costs[203]. - Deferred acquisition costs are amortized and charged to expense as premiums assumed are earned, limiting deferral to estimated realizable value[203]. - The recoverability of deferred acquisition costs is dependent on the profitability of the company's reinsurance underwriting[203]. - If underwriting ceases to be profitable, the company may need to write off a portion of deferred acquisition costs, impacting income in the period of recognition[203]. Market Risk Disclosures - As a smaller reporting company, the company is not required to provide quantitative and qualitative disclosures about market risk[204].
OXRE(OXBR) - 2022 Q1 - Earnings Call Transcript
2022-05-14 14:04
Oxbridge Re Holdings Limited (NASDAQ:OXBR) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Wrendon Timothy – Chief Financial Officer and Corporate Secretary Jay Madhu – Chairman, President and Chief Executive Officer Conference Call Participants Kent Engelke – Capitol Securities Management Operator Good afternoon. Welcome to Oxbridge Re’s First Quarter 2022 Earnings Call. My name is Chris, and I will be your conference operator this afternoon. At this time, all participants wil ...